Search results
Results from the WOW.Com Content Network
According to the Center for Public Integrity, from January 2005 through June 2006 alone, the pharmaceutical industry spent approximately $182 million on federal lobbying in the United States. [2] In 2005, the industry had 1,274 registered lobbyists in Washington, D.C. [ 3 ]
United States Army Materiel Command (AMC) Army Research, Development and Engineering Command (RDECOM) Army Research Laboratory (ARL) Army Armament Research, Development and Engineering Center (ARDEC) Engineer Research and Development Center (ERDC) U.S. Army Test and Evaluation Command (ATEC) Army Medical Research and Material Command (USAMRMC)
Despite the role that patents have played in maintaining higher drug costs for public health programs across Africa, the organization worked to minimize the effect of the Doha Declaration, which said that TRIPS should not prevent countries from dealing with public health crises and allowed for compulsory licenses.
The collapse of the deal is the latest example of how the pharmaceutical industry is battling the US government on a number of fronts, including the White House's move to license drugs that were ...
In 1997, United States law formally defined weaponizable bio-agents as "Biological Select Agents or Toxins" (BSATs) — or simply Select Agents for short [24] — which fall under the oversight of either the U.S. Department of Health and Human Services or the U.S. Department of Agriculture (or both) and which have the "potential to pose a ...
The United States Public Health Service Commissioned Corps (USPHSCC; also referred to as the Commissioned Corps of the United States Public Health Service) [11] [12] is the uniformed service branch of the United States Public Health Service and one of the eight uniformed services of the United States (along with the Army, Navy, Marine Corps, Coast Guard, Air Force, Space Force, and NOAA ...
It will also join a lawsuit filed by Merck and industry lobbying firm PhRMA, officials said Thursday. The filing due date for the briefs are Sept. 18 for the Merck lawsuit and Oct. 6 for PhRMA.
Lobbying, a standard method used to influence or change a piece of legislation, is a common practice at all levels of legislature, including the United States Congress and local legislation. [1] [2] In the U.S., direct lobbying involves direct methods used by a lobbyist when attempting to influence a legislative body.